share_log

Jasper Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Soleus Capital Master Fund, L.P.(8.8%),Soleus Capital, LLC(8.8%), etc.

SEC announcement ·  Feb 2 09:55
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more